DK1716845T3 - Formulering til dermal anvendelse - Google Patents

Formulering til dermal anvendelse

Info

Publication number
DK1716845T3
DK1716845T3 DK06113022.5T DK06113022T DK1716845T3 DK 1716845 T3 DK1716845 T3 DK 1716845T3 DK 06113022 T DK06113022 T DK 06113022T DK 1716845 T3 DK1716845 T3 DK 1716845T3
Authority
DK
Denmark
Prior art keywords
formulation
dermal use
dermal
dimethylisosorbide
antiseborrheic
Prior art date
Application number
DK06113022.5T
Other languages
English (en)
Inventor
Christel C Mueller-Goymann
Nadja Gruening
Original Assignee
Univ Braunschweig Tech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Braunschweig Tech filed Critical Univ Braunschweig Tech
Application granted granted Critical
Publication of DK1716845T3 publication Critical patent/DK1716845T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
DK06113022.5T 2005-04-26 2006-04-25 Formulering til dermal anvendelse DK1716845T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102005019628A DE102005019628A1 (de) 2005-04-26 2005-04-26 Formulierung zur dermalen Anwendung

Publications (1)

Publication Number Publication Date
DK1716845T3 true DK1716845T3 (da) 2010-06-28

Family

ID=36659712

Family Applications (1)

Application Number Title Priority Date Filing Date
DK06113022.5T DK1716845T3 (da) 2005-04-26 2006-04-25 Formulering til dermal anvendelse

Country Status (6)

Country Link
US (1) US20080227757A1 (da)
EP (1) EP1716845B1 (da)
AT (1) ATE459336T1 (da)
AU (1) AU2006201726B8 (da)
DE (2) DE102005019628A1 (da)
DK (1) DK1716845T3 (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120134921A1 (en) * 2009-06-11 2012-05-31 Photocure Asa Solid compositions comprising 5-aminolevulinic acid
RU2526803C2 (ru) * 2009-06-11 2014-08-27 ФотоКьюэр АСА Полутвердые композиции и фармацевтические продукты
DE102009038512A1 (de) * 2009-07-30 2011-02-10 Technische Universität Braunschweig Arzneimittelformulierung zur Behandlung von Nagelerkrankungen
WO2011161220A1 (en) * 2010-06-23 2011-12-29 Photocure Asa Hyperosmotic preparations comprising 5 -amino levulinic acid or derivative as photosensitizing agent
CN103405769A (zh) * 2013-03-07 2013-11-27 北京亿仁赛博医疗科技研发中心有限公司 光敏剂在制备治疗疾病的病毒灭活药物中的应用
EP3143986A1 (en) * 2015-09-21 2017-03-22 Zimmer MedizinSysteme GmbH Hydrophilic gel for topical delivery of 5-aminolevulinic acid and production thereof
EP3213744A1 (de) * 2016-03-01 2017-09-06 Chemische Fabrik Kreussler & Co. Gmbh Galenische zubereitung von nsaid
GB2546128A (en) * 2016-09-28 2017-07-12 Photocure Asa Pharamaceutical compositions comprising hexaminolevulinic acid and methods of using the same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3532562A1 (de) * 1985-09-12 1987-03-12 Dolorgiet Gmbh & Co Kg Transdermal resorbierbare, wasserhaltige zubereitungen von arylpropionsaeurederivaten und verfahren zur herstellung derselben
US5238933A (en) * 1991-10-28 1993-08-24 Sri International Skin permeation enhancer compositions
US6723750B2 (en) * 2002-03-15 2004-04-20 Allergan, Inc. Photodynamic therapy for pre-melanomas
DE10301917B4 (de) * 2003-01-17 2007-02-01 Gerhard Saalmann Verwendung von Substanzen der Porphyrinsynthese bei der Phototherapie von Haut- oder Gelenkerkrankungen des Menschen oder von Säugetieren
US8734421B2 (en) * 2003-06-30 2014-05-27 Johnson & Johnson Consumer Companies, Inc. Methods of treating pores on the skin with electricity

Also Published As

Publication number Publication date
ATE459336T1 (de) 2010-03-15
US20080227757A1 (en) 2008-09-18
AU2006201726A1 (en) 2006-11-09
DE102005019628A1 (de) 2006-11-09
AU2006201726B8 (en) 2011-03-10
EP1716845B1 (de) 2010-03-03
AU2006201726A8 (en) 2011-03-10
AU2006201726B2 (en) 2010-11-11
EP1716845A1 (de) 2006-11-02
DE502006006302D1 (de) 2010-04-15

Similar Documents

Publication Publication Date Title
DK1716845T3 (da) Formulering til dermal anvendelse
ES2570599T3 (es) Composición suave para desinfección cutánea
UA101471C2 (en) Nanoemulsions
MX2009000507A (es) Espuma farmaceutica de acidos grasos.
MX353841B (es) Composiciones antimicrobianas y metodos de uso.
CY1107732T1 (el) Συνθεση αποπηγμεντωσης για το δερμα περιλαμβανουσα αδαπαλενιο και ενα τουλαχιστον παραγοντα αποπηγμεντωσης
MX2007013623A (es) Preparacion externa para la piel.
ATE376427T1 (de) Pharmazeutische zusammensetzungen aus bartflechten (usnea barbata) und johanniskraut (hypericum perforatum) sowie ihre verwendung
EA200800777A1 (ru) Применение сложных эфиров молочной кислоты для улучшения действия пестицидов
WO2007022509A3 (en) Use of seh inhibitors as analgesics
BR112012011002A2 (pt) derivado de 1-heterodieno e agente de controle de pragas
ATE367144T1 (de) Konzentrierte, wässrige lösungen von p- methoxybenzoesäure für den einsatz in kosmetischen und dermatologischen formulierungen
DK2022332T3 (da) Vandigt desinfektionsmiddel til nedsættelse af kimtallet i luft
PL370779A1 (en) Starch derivatives, starch active substance conjugates, method for the production thereof and their use as medicaments
BR0304298A (pt) Composição contendo um ácido orgânico cosmeticamente ativo e um produto de legume
UA93529C2 (ru) Соли и смеси 9-оксоакридин-10-уксусной кислоты c 1-алкиламино-1-дезоксиполиолами
PL1868631T3 (pl) Zastosowanie związków indukujących syntezę białek SIRT przy lub dla otrzymywania kompozycji kosmetycznej lub farmaceutycznej
IL186058A0 (en) Polymorphs of 3-0-(3',3' -dimethylsuccinyl) betulinic acid di-n-methyl-d-glucamine salt
ATE374022T1 (de) Oxaliplatinlösungskonzentrate
HK1120412A1 (en) Solid pharmaceutical composition comprising telithromycin
ATE462476T1 (de) Verbesserte formulierung für hautbleichmittel
PA8786001A1 (es) Procedimiento para la preparacion de compuestos de bencimidazol tienilamina y de sus derivados utiles como agentes anhibidores del agente de intercambio sodio/protón del tipo 3"
AR056018A1 (es) Una composicion para usar en la piel
FR2883702B1 (fr) Concentre emulsifiable contenant du 2',4'-difluoro-2-(alpha, alpha-trifluoro-m-tolyloxy)-nicotinanilide et composition aqueuse obtenue par dilution du concentre
DE502005001398D1 (de) Hautpflegeprodukt enthaltend Ursolsäure und Ginkgo-Extrakt